Sabinsa raises forecasts for curcumin as new formulas, dosage forms, and breakthrough science expand the opportunities
2014 was a great year for curcumin, and Sabinsa is expecting an even better 2015 with new data from a randomized clinical trial showing the ingredient’s ability to lower blood lipid levels and ‘opening up a new direction in the already robust body of...